CTBP2P9

Across TCGA pan-cancer cohorts, CTBP2P9 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated CTBP2P9 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CTBP2P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CTBP2P9 expression acts as an unfavorable survival marker, although some lineages such as OV and STAD show a favorable association.

UCEC, THYM, and MESO are the cancer types where CTBP2P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	III,IV	0.069	0.598	<.001	126	view →
THYM	DFS	Tertile	All	0.100	0.827	<.001	90	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	27	view →
BLCA	DFS	Tertile	All	0.194	0.597	.023	18	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
GBM	OS	Tertile	All	0.257	0.445	.002	18	view →
PCPG	OS	Tertile	All	0.571	0.963	<.001	18	view →
LGG	OS	Tertile	All	0.598	0.805	.025	6	view →
OV	DFS	Tertile	IV	0.409	0.240	.049	4	view →
STAD	DFS	Tertile	II,III,IV	0.617	0.399	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

CTBP2P9–UCEC (OS)

Open the UCEC breakdown →